Prostate Cancer (Adenocarcinoma) Clinical Trials
0 recruiting
Showing 1–20 of 34 trials
Recruiting
Phase 2
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting
Phase 1Phase 2
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
Prostate Cancer (Adenocarcinoma)
The Methodist Hospital Research Institute29 enrolled1 locationNCT07182279
Recruiting
Phase 2
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Prostate CancerProstate CarcinomaProstate Neoplasm+12 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 2
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Metastatic Prostate CancerProstate Cancer (Adenocarcinoma)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins58 enrolled1 locationNCT06616597
Recruiting
Not Applicable
PSMA PET for Surveillance After Focal Therapy
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic DiseaseProstate Cancer (Diagnosis)
University of Chicago62 enrolled1 locationNCT07115914
Recruiting
ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic
University of Milano Bicocca58 enrolled1 locationNCT07407608
Recruiting
Not Applicable
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Prostate Cancer (Adenocarcinoma)
National Taipei University of Nursing and Health Sciences60 enrolled2 locationsNCT07196488
Recruiting
Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE)
Prostate Cancer (Adenocarcinoma)Localized Prostate CarcinomaProstate Hyperplasia+1 more
University of Zurich75 enrolled3 locationsNCT06834152
Recruiting
Phase 1
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
Prostate Cancer SurgeryProstate Cancer (Adenocarcinoma)Prostate CA
AdventHealth30 enrolled1 locationNCT06631521
Recruiting
Not Applicable
Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions
Prostate Cancer (Adenocarcinoma)
The Netherlands Cancer Institute54 enrolled1 locationNCT07391982
Recruiting
LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
Prostate Cancer (Adenocarcinoma)
Jules Bordet Institute110 enrolled1 locationNCT07370597
Recruiting
Phase 1Phase 2
The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University6 enrolled1 locationNCT07363382
Recruiting
Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group830 enrolled310 locationsNCT06592924
Recruiting
Not Applicable
Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery
Prostate Cancer (Adenocarcinoma)
Martini-Klinik am UKE GmbH102 enrolled2 locationsNCT07129551
Recruiting
Not Applicable
Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer
Prostate Cancer (Adenocarcinoma)
Clinique Sainte Clotilde100 enrolled1 locationNCT07344844
Recruiting
Not Applicable
Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness
Prostate Cancer (Adenocarcinoma)Low and Intermediate Risk Prostate Cancer
University Health Network, Toronto7 enrolled1 locationNCT07339943
Recruiting
Phase 1
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Acerand Therapeutics (Hong Kong) Limited67 enrolled8 locationsNCT06801236
Recruiting
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Prostate Cancer (Adenocarcinoma)Prostate Specific Antigen
Massachusetts General Hospital50 enrolled2 locationsNCT06862856
Recruiting
Not Applicable
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center80 enrolled1 locationNCT07219303
Recruiting
Phase 2
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer Clinical Trials Consortium126 enrolled2 locationsNCT06844383